RBC Capital Markets analyst Leonid Timashev increased the price target for Axsome Therapeutics (NASDAQ:AXSM) to $143 from $139, while keeping an Outperform rating on the stock. According to ...

"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

Migraines affect millions worldwide, yet remain widely misunderstood. This neurological condition extends far beyond typical headache symptoms, often ...

A common drug used to prevent migraines might have an additional benefit -- protecting women against stroke.Women takin ...

A study published in The Lancet found that sodium nitrite provoked headaches in eight out of 13 people who consumed it.

Patti Smith has spoken out following her mid-performance collapse on a stage in São Paolo, Brazil, earlier this week, calling ...

Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced pro ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.

Legendary rocker Patti Smith collapsed during a concert in Brazil Jan. 29 after dealing with a severe migraine for several ...